Nanobiotix's market cap is currently €159.35M. The company's EPS TTM is €-0.737; its P/E ratio is ―; Nanobiotix is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 30.06M	€ 4.78M	€ 10.00K	€ 50.00K	€ 68.00K
Gross Profit	€ 36.21M	€ 3.28M	€ 2.65M	€ 2.33M	€ 2.54M
Operating Income	€ -26.78M	€ -50.49M	€ -49.80M	€ -38.89M	€ -49.19M
EBITDA	€ -30.09M	€ -53.78M	€ -45.60M	€ -31.49M	€ -45.01M
Net Income	€ -39.70M	€ -57.04M	€ -47.00M	€ -33.59M	€ -50.91M
Balance Sheet
Cash & Short-Term Investments	€ 75.28M	€ 41.39M	€ 83.92M	€ 119.15M	€ 35.09M
Total Assets	€ 93.90M	€ 59.77M	€ 101.67M	€ 133.93M	€ 56.07M
Total Debt	€ 50.56M	€ 53.17M	€ 46.02M	€ 48.98M	€ 44.53M
Net Debt	€ -24.72M	€ 14.59M	€ -37.90M	€ -70.17M	€ 9.43M
Total Liabilities	€ 95.74M	€ 86.81M	€ 74.98M	€ 63.56M	€ 58.11M
Stockholders' Equity	€ -1.84M	€ -27.05M	€ 26.69M	€ 70.36M	€ -2.04M
Cash Flow
Free Cash Flow	€ -12.81M	€ -38.11M	€ -31.24M	€ -28.34M	€ -42.96M
Operating Cash Flow	€ -12.48M	€ -38.02M	€ -31.00M	€ -28.24M	€ -41.52M
Investing Cash Flow	€ -349.00K	€ 138.00K	€ -242.00K	€ -112.00K	€ -1.46M
Financing Cash Flow	€ 46.77M	€ -4.74M	€ -4.05M	€ 112.47M	€ 41.84M

Currency in EUR

Nanobiotix Earnings and Revenue History

Income Statement >

Nanobiotix Debt to Assets

Balance Sheet >

Nanobiotix Cash Flow

Cash Flow >

Nanobiotix Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing